Molecular X chromosome inactivation analysis was used to characterize three females (and their families) with severe hemophilia. First, the maternal and paternal X chromosomes were distinguished by restriction fragment length polymorphisms (RFLPs). Second, the patterns of methylation of X chromosome genes using methylation-sensitive restriction endonucleases were determined. Of the six X chromosome probes tested, only the phosphoglycerol-kinase (PGK) and hypoxanthine-phosphoribosyl-transferase (HPRT) clones were informative, indicating that other X chromosome probes are not useful for X inactivation analysis. After digestion with Hpa II or Hha I, the hybridization intensity of the RFLPs of all three mothers and an unaffected sister were diminished by 50%, consistent with random X chromosome inactivation. The methylation patterns of the X chromosomes of the affected females, however, were clearly nonrandom. Depending upon the probe and the patient, HPRT and PGK sequences were either completely methylated or unmethylated. These findings are extremely suggestive that nonrandom X chromosome inactivation (1yonization) is the basis for severe hemophilia in these females.
Introduction
Phenotypic expression of X-linked recessive diseases in females is unusual. In one instance, severe hemophilia B in a girl was due to nonrandom X chromosome inactivation caused by a deletion in one of the X chromosomes distal to a normal Factor IX allele (1) . As a means of assessing the extent of nonrandom X chromosome inactivation in other cytogenetically normal females with hemophilia, we used the technique of molecular X chromosome inactivation analysis. The ation of X chromosome genes using methylation-sensitive restriction endonucleases. X chromosome inactivation analysis was initially used to establish the clonal origin of human tumors (2) and has also been used to determine carrier status in X-linked agammaglobulinemia (3), Wiscott-Aldrich syndrome (4), and X-linked severe combined immunodeficiency (5) . In this report, molecular X chromosome inactivation analysis was used to characterize three unusual families in which one of the daughters sporadically manifested severe hemophilia.
Methods
Subjects. Two females (families B and C) were diagnosed with severe hemophilia A and one female (family A) was diagnosed with severe hemophilia B by standard measurement of clotting factor activity and antigen levels. None ofthe other family members had hemophilia, nor was there evidence that the mothers were carriers of the disease. Blood was obtained from these patients and their family members as part of an approved protocol of the Human Subjects Review Committee of the Long Island Jewish Medical Center (New Hyde Park, NY).
DNA isolation, enzyme digestion, electrophoresis, and hybridization. Blood was collected in EDTA tubes. Chromosomal DNA was isolated from white blood cell nuclei as described previously (1) . Restriction endonucleases were obtained from New England Biolabs (Beverly, MA), International Biotechnologies, Inc. (New Haven, CT), and Bethesda Research Laboratories (Gaithersburg, MD) and were used according to the conditions specified by the supplier. Agarose gel electrophoresis, Southern transfer to Nytran membranes (Schleicher & Schuell, Keene, NH), radiolabeling of molecular probes by random priming, and hybridizations were performed as described previously (1).
Molecular probes. FIX (8.13) contains two fragments of human Factor IX genomic sequences: a 2.5-kb fragment containing the d exon of the Factor IX gene and additional adjacent intron sequences (clone 8), and a triple insert ofan 0.46-kb fragment that contains most ofthe b exon, all ofthe c exon, and contiguous intron sequences (clone 13) (6). FVIII (p1 14.12) is a genomic clone containing exons 17 and 18 and contiguous introns of the human Factor VIII gene (p1 14.12) (7). Stl4 (8) and Dx 13 (9) are random X chromosome DNA probes that are linked to Factor VIII. PGK (pSPT 19.1) is an 0.8-kb fragment of the phosphoglycerol-kinase gene containing the PGK-1 promoter (10). HPRT (pPB1.7) is a 1.7-kb fragment from the first intron of the human hypoxanthine-phosphoribosyl-transferase gene (1 1).
Densitometry. The intensity of hybridization was quantitated by densitometric tracing of duplicate autoradiograms using a quantimet densitometer (Cambridge Instruments, Inc., Ossining, NY) (12) .
Results
Methylation patterns of PGK and HPRT have been extensively used for X chromosome inactivation analysis. In the process of characterizing our patients by X chromosome inac- tivation analysis, we sought to identify other X chromosome probes that could be similarly used for this type of study.
The first step was to identify RFLPs to distinguish the maternal and paternal X chromosomes. The results are summarized in Table I . Two females with severe hemophilia A (families B and C) had heterozygous RFLPs with three different Factor VIII probes, PGK, and HPRT. The previously described female with hemophilia B (family A) (and a paternal del Xq27 --ter) (1) was heterozygous for Factor IX, HPRT, and PGK.
The second step was to determine the patterns of methylation for the X chromosomes by differential sensitivity to digestion with the methylation-sensitive restriction endonucleases Hpa II or Hha I. Only the PGK (Fig. 1) and HPRT (Fig. 2) probes were informative. RFLPs of the other X chromosome DNA probes listed in Table I either completely disappeared or persisted after digestion with Hha I or Hpa II (not shown). The signal intensity of the RFLP bands of the mothers and an unaffected sister were diminished by 50%, consistent with random X chromosome inactivation. The RFLP patterns of the affected females, however, were different: the female with hemophilia B (family A) exhibited disappearance ofthe maternal PGK RFLP and persistence ofthe paternal PGK RFLP, which is consistent with nonrandom inactivation of the paternal X chromosome. For HPRT, however, the opposite result was obtained: the maternal RFLP persisted and the paternal RFLP disappeared. A previous study used a replication banding technique to show that the paternal X chromosome was nonrandomly inactivated in this girl (1) .
For the two patients with hemophilia A (families B and C), the results were identical to each other, but the converse ofthe hemophilia B patient (family A): the paternal PGK and maternal HPRT RFLPs disappeared and the maternal PGK and paternal HPRT RFLPs persisted. In the case of the fathers of the affected females, Hpa II digestion resulted in the disappearance of the PGK RFLP (Fig. 1) , but Hha I (and Hpa II, not shown) digestion diminished the HPRT RFLP signal by 25% (Fig. 2) , suggesting that in males the PGK sequence is unmethylated, whereas the HPRT sequence is relatively hypermethylated. 
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. using an HPRT probe. The same procedure as described in Fig. 1 (16) . Allele-specific methylation of the human c-Ha-ras-gene has also been described (17) . In X chromosome inactivation, regional intragenic patterns of methylation rather than ubiquitous differences may be important (18, 19 (22, 23) . The recent observation that differential methylation of the HPRT gene occurs after X chromosome inactivation suggests that methylation does not play a role in the primary events of X inactivation, but may function as part of a secondary, tissue-specific mechanism for maintaining the inactive state (24) .
There is clearly a nonrandom pattern of X chromosome methylation in the PBL of our female patients with severe hemophilia. Since X chromosome inactivation and DNA methylation occur early in embryogenesis (24) , it is reasonable to presume that lymphocytes and hepatocytes (which synthesize Factors VIII and IX) exhibit identical X chromosome methylation patterns. Therefore, these data strongly suggest that nonrandom X chromosome inactivation (lyonization) is the basis for severe hemophilia in females. 
